O	0	6	Effect
O	7	9	of
B-intervention	10	15	nurse
I-intervention	16	20	case
I-intervention	21	31	management
O	32	34	on
O	35	38	the
O	39	48	treatment
O	49	51	of
B-eligibility	52	57	older
I-eligibility	58	63	women
I-eligibility	64	68	with
I-eligibility	69	75	breast
I-eligibility	76	82	cancer
O	82	83	.

O	84	86	To
O	87	95	evaluate
O	96	99	the
O	100	106	effect
O	107	109	of
O	110	115	nurse
O	116	120	case
O	121	131	management
O	132	134	on
O	135	138	the
O	139	148	treatment
O	149	151	of
O	152	157	older
O	158	163	women
O	164	168	with
O	169	175	breast
O	176	182	cancer
O	182	183	.

O	184	194	Randomized
O	195	206	prospective
O	207	212	trial
O	212	213	.

O	214	219	Sixty
O	220	228	surgeons
O	229	239	practicing
O	240	242	at
O	243	245	13
O	246	255	community
O	256	259	and
O	260	263	two
O	264	270	public
O	271	280	hospitals
O	281	283	in
O	284	293	southeast
O	294	299	Texas
O	299	300	.

B-total-participants	301	306	Three
I-total-participants	307	314	hundred
I-total-participants	315	321	thirty
I-total-participants	321	322	-
I-total-participants	322	326	five
O	327	332	women
O	333	334	(
B-control-participants	334	337	166
B-control	338	345	control
O	346	349	and
B-intervention-participants	350	353	169
O	354	366	intervention
O	366	367	)
B-age	368	372	aged
I-age	373	375	65
I-age	376	379	and
I-age	380	385	older
O	386	391	newly
O	392	401	diagnosed
O	402	406	with
O	407	413	breast
O	414	420	cancer
O	420	421	.

O	422	427	Women
O	428	434	seeing
O	435	443	surgeons
O	444	454	randomized
O	455	457	to
O	458	461	the
O	462	474	intervention
O	475	480	group
O	481	489	received
O	490	493	the
O	494	502	services
O	503	505	of
O	506	507	a
O	508	513	nurse
O	514	518	case
O	519	526	manager
O	527	530	for
O	531	533	12
O	534	540	months
O	541	546	after
O	547	550	the
O	551	560	diagnosis
O	561	563	of
O	564	570	breast
O	571	577	cancer
O	577	578	.

O	579	582	The
O	583	590	primary
O	591	598	outcome
O	599	602	was
O	603	606	the
B-outcome-Measure	607	611	type
I-outcome-Measure	612	615	and
I-outcome-Measure	616	619	use
I-outcome-Measure	620	622	of
I-outcome-Measure	623	629	cancer
I-outcome-Measure	629	630	-
I-outcome-Measure	630	638	specific
I-outcome-Measure	639	648	therapies
O	649	657	received
O	658	660	in
O	661	664	the
O	665	670	first
O	671	672	6
O	673	679	months
O	680	685	after
O	686	695	diagnosis
O	695	696	.

O	697	706	Secondary
O	707	715	outcomes
O	716	720	were
B-outcome-Measure	721	728	patient
I-outcome-Measure	729	741	satisfaction
O	742	745	and
B-outcome-Measure	746	749	arm
I-outcome-Measure	750	758	function
O	759	761	on
O	762	765	the
O	766	774	affected
O	775	779	side
O	780	781	2
O	782	788	months
O	789	794	after
O	795	804	diagnosis
O	804	805	.

O	806	810	More
O	811	816	women
O	817	819	in
O	820	823	the
O	824	836	intervention
O	837	842	group
B-outcome	843	851	received
I-outcome	852	858	breast
I-outcome	858	859	-
I-outcome	859	869	conserving
I-outcome	870	877	surgery
O	878	879	(
B-iv-bin-percent	879	881	28
I-iv-bin-percent	881	882	.
I-iv-bin-percent	882	883	6
I-iv-bin-percent	883	884	%
O	885	887	vs
B-cv-bin-percent	888	890	18
I-cv-bin-percent	890	891	.
I-cv-bin-percent	891	892	7
I-cv-bin-percent	892	893	%
O	893	894	;
O	895	896	P
O	896	897	=
O	897	898	.
O	898	901	031
O	901	902	)
O	903	906	and
B-outcome	907	916	radiation
I-outcome	917	924	therapy
O	925	926	(
B-iv-bin-percent	926	928	36
I-iv-bin-percent	928	929	.
I-iv-bin-percent	929	930	0
I-iv-bin-percent	930	931	%
O	932	934	vs
B-cv-bin-percent	935	937	19
I-cv-bin-percent	937	938	.
I-cv-bin-percent	938	939	0
I-cv-bin-percent	939	940	%
O	940	941	;
O	942	943	P
O	943	944	=
O	944	945	.
O	945	948	003
O	948	949	)
O	949	950	.

O	951	953	Of
O	954	959	women
O	960	970	undergoing
O	971	977	breast
O	977	978	-
O	978	988	conserving
O	989	996	surgery
O	996	997	,
O	998	1005	greater
O	1006	1017	percentages
O	1018	1020	in
O	1021	1024	the
O	1025	1029	case
O	1030	1040	management
O	1041	1046	group
B-outcome	1047	1055	received
I-outcome	1056	1064	adjuvant
I-outcome	1065	1074	radiation
O	1075	1076	(
B-iv-bin-percent	1076	1078	78
I-iv-bin-percent	1078	1079	.
I-iv-bin-percent	1079	1080	3
I-iv-bin-percent	1080	1081	%
O	1082	1084	vs
B-cv-bin-percent	1085	1087	44
I-cv-bin-percent	1087	1088	.
I-cv-bin-percent	1088	1089	8
I-cv-bin-percent	1089	1090	%
O	1090	1091	;
O	1092	1093	P
O	1093	1094	=
O	1094	1095	.
O	1095	1098	001
O	1098	1099	)
O	1100	1103	and
B-outcome	1104	1112	axillary
I-outcome	1113	1123	dissection
O	1124	1125	(
B-iv-bin-percent	1125	1127	71
I-iv-bin-percent	1127	1128	.
I-iv-bin-percent	1128	1129	4
I-iv-bin-percent	1129	1130	%
O	1131	1133	vs
B-cv-bin-percent	1134	1136	44
I-cv-bin-percent	1136	1137	.
I-cv-bin-percent	1137	1138	8
I-cv-bin-percent	1138	1139	%
O	1139	1140	;
O	1141	1142	P
O	1142	1143	=
O	1143	1144	.
O	1144	1147	057
O	1147	1148	)
O	1148	1149	.

O	1150	1155	Women
O	1156	1158	in
O	1159	1162	the
O	1163	1167	case
O	1168	1178	management
O	1179	1184	group
O	1185	1189	were
O	1190	1194	also
O	1195	1199	more
B-outcome	1200	1206	likely
I-outcome	1207	1209	to
I-outcome	1210	1217	receive
I-outcome	1218	1222	more
I-outcome	1223	1229	breast
I-outcome	1230	1244	reconstruction
I-outcome	1245	1252	surgery
O	1253	1254	(
B-iv-bin-percent	1254	1255	9
I-iv-bin-percent	1255	1256	.
I-iv-bin-percent	1256	1257	3
I-iv-bin-percent	1257	1258	%
O	1259	1261	vs
B-cv-bin-percent	1262	1263	2
I-cv-bin-percent	1263	1264	.
I-cv-bin-percent	1264	1265	6
I-cv-bin-percent	1265	1266	%
O	1266	1267	,
O	1268	1269	P
O	1269	1270	=
O	1270	1271	.
O	1271	1274	054
O	1274	1275	)
O	1275	1276	,
O	1277	1280	and
O	1281	1286	women
O	1287	1289	in
O	1290	1293	the
O	1294	1298	case
O	1299	1309	management
O	1310	1315	group
O	1316	1320	with
O	1321	1329	advanced
O	1330	1336	cancer
O	1337	1341	were
B-outcome	1342	1346	more
I-outcome	1347	1353	likely
I-outcome	1354	1356	to
I-outcome	1357	1364	receive
I-outcome	1365	1377	chemotherapy
O	1378	1379	(
B-iv-bin-percent	1379	1381	72
I-iv-bin-percent	1381	1382	.
I-iv-bin-percent	1382	1383	7
I-iv-bin-percent	1383	1384	%
O	1385	1387	vs
B-cv-bin-percent	1388	1390	30
I-cv-bin-percent	1390	1391	.
I-cv-bin-percent	1391	1392	0
I-cv-bin-percent	1392	1393	%
O	1393	1394	,
O	1395	1396	P
O	1396	1397	=
O	1397	1398	.
O	1398	1401	057
O	1401	1402	)
O	1402	1403	.

O	1404	1407	Two
O	1408	1414	months
O	1415	1420	after
O	1421	1428	surgery
O	1428	1429	,
O	1430	1436	higher
O	1437	1448	percentages
O	1449	1451	of
O	1452	1457	women
O	1458	1460	in
O	1461	1464	the
O	1465	1469	case
O	1470	1477	manager
O	1478	1483	group
O	1484	1487	had
B-outcome	1488	1494	normal
I-outcome	1495	1498	arm
I-outcome	1499	1507	function
O	1508	1509	(
B-iv-bin-percent	1509	1511	93
I-iv-bin-percent	1511	1512	%
O	1513	1515	vs
B-cv-bin-percent	1516	1518	84
I-cv-bin-percent	1518	1519	%
O	1519	1520	;
O	1521	1522	P
O	1522	1523	=
O	1523	1524	.
O	1524	1527	037
O	1527	1528	)
O	1529	1532	and
O	1533	1537	were
O	1538	1542	more
B-outcome	1543	1549	likely
I-outcome	1550	1552	to
I-outcome	1553	1558	state
I-outcome	1559	1563	that
I-outcome	1564	1568	they
I-outcome	1569	1572	had
I-outcome	1573	1574	a
I-outcome	1575	1579	real
I-outcome	1580	1586	choice
I-outcome	1587	1589	in
I-outcome	1590	1595	their
I-outcome	1596	1605	treatment
O	1606	1607	(
B-iv-bin-percent	1607	1609	82
I-iv-bin-percent	1609	1610	.
I-iv-bin-percent	1610	1611	2
I-iv-bin-percent	1611	1612	%
O	1613	1615	vs
B-cv-bin-percent	1616	1618	69
I-cv-bin-percent	1618	1619	.
I-cv-bin-percent	1619	1620	9
I-cv-bin-percent	1620	1621	%
O	1621	1622	,
O	1623	1624	P
O	1624	1625	=
O	1625	1626	.
O	1626	1629	020
O	1629	1630	)
O	1630	1631	.

O	1632	1637	Women
O	1638	1642	with
O	1643	1653	indicators
O	1654	1656	of
O	1657	1661	poor
O	1662	1668	social
O	1669	1676	support
O	1677	1681	were
O	1682	1686	more
O	1687	1693	likely
O	1694	1696	to
O	1697	1704	benefit
O	1705	1709	from
O	1710	1715	nurse
O	1716	1720	case
O	1721	1731	management
O	1731	1732	.

O	1733	1738	Nurse
O	1739	1743	case
O	1744	1754	management
O	1755	1762	results
O	1763	1765	in
O	1766	1770	more
O	1771	1782	appropriate
O	1783	1793	management
O	1794	1796	of
O	1797	1802	older
O	1803	1808	women
O	1809	1813	with
O	1814	1820	breast
O	1821	1827	cancer
O	1827	1828	.
